Prostate Cancer - Results from #19420

Predicting pathologic outcomes in patients undergoing robot-assisted radical prostatectomy for high risk prostate cancer: A preoperative nomogram - Abstract January 22, 2015

Proton beam therapy for the treatment of prostate cancer - Abstract January 22, 2015

Stage pT0 after radical prostatectomy: A diagnostic dilemma - Abstract January 22, 2015

Providing clinicians and patients with actual prognosis: Cancer in the context of competing causes of death - Abstract January 22, 2015

The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: Validation in a managed care setting - Abstract January 22, 2015

ASCO teams with SAP to help transform cancer patient care January 21, 2015

Investigation of an adaptive treatment regime for prostate radiation therapy - Abstract January 20, 2015

Margin involvement at prostatectomy for clinically localized prostate cancer: Does a low-risk group exist? - Abstract January 20, 2015

Will multi-parametric magnetic resonance imaging be the future tool to detect clinically significant prostate cancer? - Abstract January 20, 2015

Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413 - Abstract January 20, 2015

Prostate cancer collaborative stage data items-their definitions, quality, usage, and clinical implications: A review of SEER data for 2004-2010 - Abstract January 20, 2015

Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility - Abstract January 20, 2015

Staging lymphadenectomy in patients with localized high risk prostate cancer: Comparison of the laparoendoscopic single site (LESS) technique with conventional multiport laparoscopy - Abstract January 20, 2015

The HAROW study: An example of outcomes research: A prospective, non-interventional study comparing treatment options in localized prostate cancer - Abstract January 20, 2015

Dynamic contrast enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post-failed external beam radiation therapy - Abstract January 19, 2015

Active surveillance in patients with a PSA >10 ng/mL - Abstract January 19, 2015

A guide to the management of urologic dilemmas for the primary care physician (PCP) - Abstract January 19, 2015

Local recurrence map to guide target volume delineation after radical prostatectomy - Abstract January 19, 2015

Apparent diffusion coefficient ratio correlates significantly with prostate cancer Gleason score at final pathology - Abstract January 19, 2015

Prostate cancer risk prediction based on complete prostate cancer family history - Abstract January 19, 2015

Page 972 of 1457